FRM
RGC icon

Fox Run Management’s Regencell Bioscience RGC Stock Holding History

Fox Run Management’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
+20,691
New +$497K 0.02% 862

Other funds holding RGC

CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Fox Run Management's RGC Position: Q2 2026 in Review

Fox Run Management opened a new position in Regencell Bioscience (RGC) in Q2 2026: 20,691 shares worth $126K. The stake represents 0.02% of the portfolio and ranks #862 among its holdings.

8 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Fox Run Management held 20,691 shares of Regencell Bioscience worth $126K as of Q2 2026.
  • Regencell Bioscience was a new Fox Run Management position in Q2 2026.
  • Regencell Bioscience made up 0.02% of Fox Run Management's portfolio in Q2 2026, its #862 holding.
  • 8 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.